
The global tissue diagnostics market size was valued at USD 602.95 Million in 2024 and is expected to reach USD 1,005.40 Million by 2032, at a CAGR of 6.60% during the forecast period
The market growth in tissue diagnostics is largely fueled by the increasing prevalence of cancer and other chronic diseases worldwide, along with significant technological progress, leading to enhanced diagnostic accuracy and efficiency in both clinical and research settings
Furthermore, rising demand for precise, early detection and personalized medicine approaches is establishing advanced tissue diagnostics solutions, such as digital pathology and molecular diagnostics, as the modern standard for disease management. These converging factors are accelerating the uptake of Tissue Diagnostics solutions, thereby significantly boosting the industry's growth

